Monthly Archives: August 2021

Ladies, Here’s How to Prevent Top 7 Threats to Your Health – Baptist Health South Florida

Posted: August 18, 2021 at 2:37 am

Two out of every three caregivers in the U.S. are women. That means they provide daily or regular support to children, adults, or people with chronic illnesses or disabilities, says the U.S. Centers for Disease Control and Prevention (CDC). But while women tend to care for others, they tend to sacrifice their own physical or mental health, the CDC adds.

Many of the top health threats to women can be prevented, including the top causes of death among adult women in the U.S. heart disease, cancer, chronic lower respiratory disease, stroke, Alzheimers disease and unintentional injuries. Women tend to be underdiagnosed with heart disease, the No. 1 cause of death for both men and women.

During the COVID-19 pandemic, surveys found that women reported skipping preventive health services, such as their yearly check-up or routine tests, more so than men. Usually, that trend is reversed, with women tending to their healthcare needs more. But during the pandemic, more women took on roles as teachers in their homes and caregivers for elderly family members..

Nonetheless, primary care doctors warn that women who put off taking care of their own health to care for others often end up with conditions that could have been treated more easily in their earlier stages.

Women need to take some time to make sure they get their regular checkups and necessary health screenings, depending on their age and overall health, said Kamaljit Kaur, M.D., a family medicine physician with Baptist Health Primary Care. Even if we only see them once a year for their checkups, we can see subtle changes that could indicate a risk for developing or the presence of disease.

A checkups blood work can show the presence of an infection with elevated white blood cells, anemia or internal bleeding with too few red blood cells, high blood sugar that may indicate diabetes, and thyroid, kidney and liver function. A mental health screening can reveal depression, anxiety and sleep disorders, which can lead to other health problems.

We also discuss vital lifestyle factors such as weight management, proper nutrition and regular exercise to keep risk factors under control for heart disease, diabetes and other potentially serious conditions, said Dr. Kaur.

Here are the top threats to womens health:

Unhealthy diet

The foods you eat affect your health. Eating healthier can lower your risk of heart disease and stroke, diabetes and other chronic conditions.

Not enough exercise

Being physically active is good for your heart and overall health, including mental health. People who are not active have double the risk of heart disease and stroke, and higher risk diabetes, dementia, and some cancers. Exercise is one of the most vital steps you can take to better health.

Unhealthy weight

Most people struggle with their weight at some point in their lives. Being overweight can lead to high blood pressure, high cholesterol, diabetes and sleep apnea. Obesity can double your chance of heart disease. Consult with your doctor about lifestyle modification and the ideal weight range for you.

Smoking

Smoking triples the risk of dying from heart disease and stroke in middle-aged women. Quitting is one of the best things you can do to prevent heart disease and stroke.

Stress

If you feel regularly pressured because of workloads at home and the office, your physical well-being, lifestyle habits, and mental health will suffer and so can your immune system and the ability to fight off disease. Take steps to reduce stress.

Too much alcohol

Heavy drinking and binge drinking are risk factors for high blood pressure, heart disease and stroke. Alcohol may also cause problems by interacting with your medications.

Birth control and hormone replacement therapy (HRT)

Medications that contain estrogen the female hormone increase the risk of heart attack, stroke and mini-stroke (TIA). Consult with your doctor about these medications and their side effects.

Tags: Baptist Health Primary Care, women's health

More:
Ladies, Here's How to Prevent Top 7 Threats to Your Health - Baptist Health South Florida

Posted in Hormone Replacement Therapy | Comments Off on Ladies, Here’s How to Prevent Top 7 Threats to Your Health – Baptist Health South Florida

Puppies Puppies (Jade Kuriki-Olivo) on transition, retrospection, and year of protest – Artforum

Posted: August 18, 2021 at 2:37 am

Puppies Puppies (Jade Kuriki Olivo), Brain on Estrogen, progesterone, spironolactone, Truvada, Advil and Marijuana, 2018, cow brain, marijuana leaf, progesterone, estrogen, spironolactone, prep and pain killers. Photo: Courtesy the artist.

Jade Kuriki Olivos retrospective at the Kunsthaus Glarus in Switzerland brings together the Brooklyn-based artists work from the past decade. On view through August 22, the show maps the evolution of her practice as she transitioned from working under the guise of Puppies Puppies to living as an openly trans woman. Here, Olivo reflects on this transformation and discusses refusing to hide, the turning point represented by this exhibition, and the weekly Stonewall Protests for Black Trans Liberation that have kept her going over the past year.

I WAS HIDING from the world for a long time. In some ways, it was because it was so terrifying to beor even think about beinga trans woman. It felt like jumping off a cliff when I decided that it was what I wanted and needed in life.

Trans women have been consistently erased from historyour voices have been erasedso it is revolutionary for me, and for every trans person, especially BIPOC, gender-nonconforming, and two-spirit people, to be in control of the way our voices go out into the world. I still dont do many interviews, but unlike beforewhen my ex-husband or someone else would speak for me and I would be in a costume or sleeping on a sleeping pillnow I speak for myself. It means something very differentto be hidden as a trans woman. At other points in history, I wouldnt have been able to exist. So when I came out, I exposed myself fully and physically in a nude performance in Paris as a way of saying, Im here and Im not going to hide anymore. I couldnt be out as a trans woman and have hiding be a part of my work. I also wanted to document the changes in my body as my hormone-replacement therapy continued.

This is part of the arc of my exhibition at the Kunsthaus Glarus. It was emotional pulling this show together because I really wanted people to understand the evolution thats happened within me. The show covers eleven years of work. I called it a retrospective because I was thinking about how the amount of time that one is given, that a person is allowed to exist, is different for different people. Trans women often dont live as long as other people. It creates a different way of relating to time. Its definitely more precious for me, also having had a brain tumor.

The show marks a new way of making work for me. Ive always worked with other artists, so collaboration is nothing new, but Im moving into a more curatorial rolebecoming a conduit or a pathwayso that I can give a platform to other artists, especially a growing family of trans/GNC/2S+ artists. Going forward, when an institution asks me to do a solo show, I will invite another artist to do their own solo show, and they can decide how or if they want that to be associated with me. This is the direction I want to go in, and Im doing sex work and figuring out a way to survive so I can keep moving toward it. This new chapter begins with Bri Williams and Elliot Reeds exhibitions opening at Glarus in September.

Next to giving other artists I believe in space to express themselves, Stonewall Protests is the part of my life I am most passionate about. Stonewall is organized by Qween Jean and Joela Rivera, who have been holding weekly demonstrations for the past year in the wake of the murder of George Floyd. They are really the civil-rights leaders of now. Ive been protesting since the age of sixteen, but when I finally found Stonewall Protests at thirty-one, I was like, Oh my God, you found your family and your home. I also found a reason to keep going at a time when my art practice was not fulfilling me. It is a healing space. Stonewall is first and foremost a leading formation within the current Black Trans Lives Matter movement. The protests relate in some ways to the ballroom scene, which was founded by Black and Latinx trans women in New York City, specifically in Harlem, and brings that culture to protesting. An amazing group of bikers called Riders4Rights block intersections so the space can become a dance floor where people are able to express themselves to their fullest and feel safe enough to do so. There are different chants and a drum line and music made by a fantastic group called Musicians United NYC. A huge part of the Stonewall protests are mutual-aid events which emphasize the need to support one another, as well as the communities some Stonewall protesters live or grew up in.

In different Indigenous histories, trans people have been identified as healers or helpers, and Im drawn to this way of existing as a kind of sacred work. This is a practice I became familiar with through my father, who was Indigenous and taught me what he knew, and from my chosen Indigenous queer family members over time. In articulating all this, and thinking about when art and life blend together, Ive been really grateful to reflect on this evolution. As Puppies Puppies, I was making meme videos, really concealed from the world in this little shell. And now this is whats happening. Its my life and Im here.

As told to Camila McHugh

Read more here:
Puppies Puppies (Jade Kuriki-Olivo) on transition, retrospection, and year of protest - Artforum

Posted in Hormone Replacement Therapy | Comments Off on Puppies Puppies (Jade Kuriki-Olivo) on transition, retrospection, and year of protest – Artforum

Health tips from Dr. Oz and Dr. Roizen for 8-17-21 – The Dispatch – The Commercial Dispatch

Posted: August 18, 2021 at 2:37 am

Attitude and action to win over this past years challengesLive long and prosper. That famous line from the Vulcan Mr. Spock (played by Leonard Nimoy) should be your motto for the coming year. And heres how to do it despite the recent news about just how tough its been.

A study that looked at 29 folks, ages 90 to 100, uncovered two powerful secrets to longevity: acceptance of and recovery from things you cant change and an impulse to fight for the things you can alter. This is valuable information especially now that life expectancy in the U.S. is falling.

COVID-19 contributed to a decline in life expectancy from age 78.8 in 2019 to age 77.3 in 2020, according to the National Center for Health Statistics. In addition, more than 93,000 people died from drug overdoses a 30 percent increase over 2019. Homicides and deaths from diabetes and chronic liver disease also made major dents in longevity.

So what can you do to buck this trend?1. Get vaccinated pronto. 100 percent of the deaths from COVID-19 in June in Maryland were among nonvaccinated people.

2. Reassert control over your health. See your doctor for checkups and tests, especially if you have diabetes or other chronic conditions and nonalcoholic fatty liver disease. Reach out to support groups if you have alcohol- or substance-related disorders or suicidal thoughts and behavior.

3. Revamp your nutrition and your physical activity routine. Nutrition influences everything from longevity to mood. Theres great guidance in Dr. Mikes book What to Eat When and at DoctorOz.com, click on OZtube/Body.

If you arent getting vaccinated for yourself do it for your pet!When John Legend did the ad This Shot Is Our Shot to encourage people to get a COVID-19 vaccine and then put his inoculation up online, he was thinking about all the heartache that could be prevented by protecting folks from contracting the sometimes-fatal infection. But we bet John and his wife Chrissy Teigen who posted info on her shot on Facebook didnt know what a huge benefit their inoculations would be to their bulldogs Pablo, Penny and Pippa and their poodle named Petey.

It turns out that when a pet owner gets COVID-19, 67 percent of housecats and 43 percent of dogs also become infected. Thats the conclusion of researchers from Canadas University of Guelph, who did a study of 48 cats and 54 dogs from 77 households in which an owner had been diagnosed with COVID-19. Their paper, presented at the European Congress of Clinical Microbiology & Infectious Diseases 2021, found that while most infected pets were asymptomatic, 20 percent of the dogs experienced lack of energy and loss of appetite, a cough or diarrhea; 27 percent of cats ended up with a runny nose and difficulty breathing.

The researchers advice: If you get COVID-19, stay away from your pet, and dont allow it to sleep with you. Also smart: If you have COVID-19 in your house, keep your pet away from other people and pets. Once a cat or dog becomes infected, pet-to-pet and pet-to-human transmission cannot be ruled out say the researchers.

How to stay cool in a heat waveMartha and the Vandellas sang about the torment of a Heat Wave in their 1963 hit: Its like a heat wave/burnin in my heart/ Its like a heat wave/Its tearin me apart. They did a pretty good job of predicting the effect of the scorching temperatures the U.S. has been experiencing this summer.

At least 67 weather stations from Washington State through New Mexico have recorded their hottest temperatures ever, according to the National Weather Service. And as risky as that is for the earths and peoples future, it also poses an immediate threat to you. High temperatures can cause dehydration, heatstroke, heat exhaustion and heat cramps; strain the cardiovascular and respiratory systems; and even increase interpersonal conflict. Research also shows strong links between climate crises and development of depression, anxiety and PTSD. So how can you stay cool, calm and collected when its steamy outside?

BIG NEWS: Dont use an electric fan when the indoor air temperature is over 95 degrees. The breeze can actually cause your body to gain heat instead of losing it!

If you have air conditioning, use it or go to an air-conditioned building or cooling center. For locations, Google cooling centers (and the name of your town). And (duh!) wear lightweight, light-colored, loose-fitting clothing.

In a cool environment, drink a tall glass of plain water every couple hours. In the heat, have a water bottle with you and sip every 10-15 minutes. Nothing sugary.

Exercise (keep doing it!) indoors in a cool place.

Think, sweat, think sweat that may delay dementiaBrute strength: 6 feet 9 inch tall Game of Thrones actor Hafthor Bjornsson set a world deadlifting record by lifting 1,104 pounds. Brain power: Dr. Sho Yano has an IQ of 200, started college at age 9 and earned an M.D. and Ph.D. by the time he was 21.

Imagine if such brains and brawn were found in one person. Well, they can be in you! And you dont have to hold the worlds record in both strength and intelligence to get the benefits of that combination: a reduced risk of Alzheimers and a healthier cardio and respiratory system. So heres how to harness the benefits.

A study in the journal Neurology followed 1,978 people, average age 80, and found that doing simple cognitive exercises such as reading, writing letters, playing card games and doing puzzles may delay the onset of Alzheimers disease by up to five years. And brain workouts later in life not as a younger person are what delayed the participants cognitive decline.

While youre strengthening your brain, pay attention to your body. Another research team found that one year of moderate- to vigorous-intensity aerobic walking two to three times a week for 30 minutes gradually increasing to four to five times weekly with two sessions of high intensity improves cardiorespiratory fitness, cerebral blood flow, memory and executive function in folks with mild cognitive impairment. The researchers say that also may reduce your risk of Alzheimers. We say combine brains and brawn and youll have a win-win well into your 80s and 90s!

The alpha and omega-3 of a longer lifeAn adult male bear on Kodiak Island in Alaska eats more than 6,000 pounds of salmon a year; females gobble up about half of that. And without any bagels! Fortunately, to get the remarkable benefits of eating omega-3-rich foods, you only need to eat a 3- to 6-ounce serving of salmon regularly. Dr. Mike loves salmon burgers even for breakfast. For lunch or dinner, he adds olives and broccoli or grilled vegetables.

A new study in the American Journal of Clinical Nutrition looked at data from blood tests on more than 2,200 people over age 65 for an average of 11 years. The researchers from The Fatty Acid Research Institute in the United States and colleagues in universities in the U.S. and Canada found that folks with high levels of omega-3 fatty acids in their blood saw an increase in life expectancy of almost five years. Thats a huge increase in longevity from simply enjoying incredibly tasty foods.

The alpha and omega-3 of your choices: In every 3.5-ounce serving, wild salmon has 2,260 milligrams, herring 2,366 milligrams, sardines 1,480 milligrams and anchovies 2,113 milligrams. Flaxseed delivers 7,260 milligrams per tablespoon; and chia seeds and walnuts dish up 5,060 milligrams and 2,570 milligrams per ounce respectively. The benefit of adding these foods (in human size portions) is clear. According to the study author: It reinforces the idea that small changes in diet in the right direction can have a much more powerful effect than we think, and it is never too late or too early to make these changes.

Shades of brain healthIn 1986, when Cyndi Lauper sang True Colors I see your true colors shining through/I see your true colors and thats why I love you/So dont be afraid to let them show she had no idea just how important it was for everyone to put those true colors on display on their breakfast, lunch and dinner plates! But a new study in the journal Neurology reveals the power of colorful fruits and vegetables to protect you from cognitive decline as you get older.

The study, led by renowned Harvard nutrition researcher Walter Willet, followed almost 50,000 men and women, average age 51 at the start of the study, for 20 years. It revealed that eating flavonoid-rich, colorful foods such as apples; celery; red, blue and purple berries and grapes; hot and sweet peppers; eggplant; plums; carrots; citrus fruits; and even thyme and parsley can reduce your risk for encroaching dementia by 20 percent.

The study found that taking in 600 milligrams of flavonoids a day is what it takes to help combat cognitive decline 3.5 ounces of strawberries dishes up around 180 milligrams; a medium apple, 113 milligrams. In the U.S., adults only get about 200 to 250 milligrams a day, just a bit above the study group with the lowest intake and greatest risk of cognition problems.

If you make an effort to increase your intake, youll gain flavonoids neuroprotection. They also turn out to be anti-inflammatory and anti-diabetic. So make your life a bowl full of cherries and other colorful flavonoid-rich foods.

Foods that damage your immune strengthKryptonite immobilizes Superman. Spider-Mans archenemy, Venom, changes from predator to weakling at the sight of a flame. And you? Well, it turns out certain foods have superpowers that weaken your immune system, transforming you from super-germ fighter to a target for everything from the common cold to COVID-19. The most immune-weakening consumables are:

Excess alcohol. Whether its a daily overdose or you binge once a week, youre increasing your risk for pneumonia and acute respiratory stress syndromes. That could potentially impact the outcome of COVID-19. It also leads to slower recovery from infection and post-op complications.

Too much salt. That causes a cascade of events, starting with the kidneys excreting excess sodium and ending with a reduction in your bodys ability to fight bacterial infections. As little as 6 extra grams a day has that effect. Your daily average should be below 3 grams a day.

Added sugar. As little as 3.5 ounces (thats in a 16-ounce Coke, a Big Mac and a slice of pecan pie) can reduce the ability of immune cells to neutralize bacteria for up to five hours.

Highly processed foods. Stripped of fiber, these alter the mix of microbes in your gut biome, where 70 percent to 80 percent of immune cells hang out, making them less able to battle viruses. Getting adequate fiber (25 to 30 grams daily) has been shown to strengthen your flu-fighting powers. Whole cereals, veggies and fruit, and beans are go-to sources plus they supply vitamins A and C, folate and bioactive compounds that also boost immune health.

Playing hooky from your statin? Look for some new alternativesThere are over 1 million students in the New York City public school system, and more than 22 percent of them are chronically absent from the classroom (pre-pandemic). Thats not good for their future. But even more adults around 50 percent fail to show up for their life-saving daily dose of a statin. Now, that really threatens their future.

Fortunately, there are new cholesterol-fighting medications that even your doc might not be aware of, according to a new JAMA Insights Clinical Update. So if youre not taking your prescribed statin or your lousy LDL cholesterol level is too high, ask about trying one of the following drugs on its own or with a statin. Most are covered by insurance if youre statin resistant or have had statin myopathy from two different statins.

PSCK-9 inhibitors. A monoclonal antibody administered by injection every two to four weeks, it reduces LDL by 50 percent to 60 percent and is well-tolerated. Check to see if your insurance covers it.Ezetimibe. An inexpensive generic, this cuts intestinal absorption of cholesterol and reduces LDL levels by 10 percent to 20 percent. Good in combo with a statin.

Bempedoic acid. It lowers LDL by about 20 percent with few side effects. Its not yet known how much it reduces the risk of atherosclerotic-related cardiovascular disease; check price and insurance coverage.

Icosapent ethyl. An omega-3 fatty acid that, when added to statin therapy for patients with high triglyceride levels, can reduce atherosclerotic cardiovascular disease risk by 25 percent. Highly variable out-of-pocket cost.

As you age you may need fewer calories but more nutrientsThe worlds oldest magic trick, acetabula et calculi, reportedly dates back to early Rome. Today, its known as cups and balls and while there are endless variations, it all comes down to trying to figure out how small balls pop in and out of three upside-down cups unseen.

Making sure you get enough nutrition as you get older also requires a sleight of hand. You need extra nutrients to protect your strength, cognition, immune function and bone, eye and heart health, while you take in fewer calories daily. Here are four nutrients you should pack into every day.

Calcium: For bone health, aim for three servings a day of fat-free dairy, two servings daily of dark leafy greens like kale, spinach and collards. Also good: canned fish, like sardines.

Vitamin D: Get a good daily dose from fish such as salmon, mushrooms and fortified foods. Get your blood level checked: Most folks need a supplement too. It helps with immune function and bone strength.

Vitamin B12: Essential for nerve and blood cell health, its in fortified whole-grain cereals, lean meat and fish. A blood test will show if you need a supplement.

Protein: Whole grains and legumes, tofu, fish, nuts and lean poultry can deliver the protein you need to gain and maintain muscle mass and function. A 150- to 160-pound senior might need 65 to 70 grams daily. That could come from 6 ounces of salmon (40 grams), 3 ounces of white meat turkey (24 grams) and 1 cup of brown rice (5 grams).

The amazing power of diet to cool menopause hot flashesIn 2014, then 61-year-old Emma Thompson joked about her hot flashes as she accepted a best actress award from the National Board of Review for her role in Saving Mr. Banks: Its such a cold night. You know, its the first time Ive been actively grateful for the menopause. Sound familiar?

Around 85 percent of postmenopausal women say symptoms such as hot flashes, palpitations and insomnia define the months or years around the cessation of menstruation. Many just tough it out, because for years they were told to take hormone replacement therapy, then told, No, hormone therapy is too risky, then, that its really OK if done immediately after menopause and for no more than 10-20 years (the correct information in our opinion if you also take low-dose aspirin).

Too bad this new study, led by Physicians for Responsible Medicines founding president Neal Barnard, wasnt around sooner. Its a real game changer. During the 12-week study, the research published in the journal Menopause found that a plant-based diet, rich in soy, reduces moderate-to-severe hot flashes by 84 percent! Close to 60 percent of participants became totally free of moderate-to-severe hot flashes and women who experienced mild hot flashes saw them decrease by 79 percent.

The diet that produced these remarkable results was low-fat and vegan, based on fruits, vegetables, whole grains and legumes, reduced intake of added oils and fatty foods, and heres the kicker 1/2 cup of cooked non-GMO soybeans daily. In our humble opinion, this diet deserves to be adopted by any woman whos contending with menopause symptoms.

Mehmet Oz, M.D. is host of The Dr. Oz Show, and Mike Roizen, M.D. is Chief Wellness Officer and Chair of Wellness Institute at Cleveland Clinic. To live your healthiest, tune into The Dr. Oz Show or visit http://www.sharecare.com.

Read the original post:
Health tips from Dr. Oz and Dr. Roizen for 8-17-21 - The Dispatch - The Commercial Dispatch

Posted in Hormone Replacement Therapy | Comments Off on Health tips from Dr. Oz and Dr. Roizen for 8-17-21 – The Dispatch – The Commercial Dispatch

Xeris Pharmaceuticals Announces FDA Acceptance of its IND Application for XeriSol Levothyroxine (XP-8121) for the Treatment of Hypothyroidism – Yahoo…

Posted: August 18, 2021 at 2:37 am

Currently recruiting healthy participants

CHICAGO, August 11, 2021--(BUSINESS WIRE)--Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a pharmaceutical company leveraging its novel formulation technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, today announced that the Food and Drug Administration (FDA) has allowed the Investigational New Drug Application (IND) for its XeriSol levothyroxine for hypothyroidism to proceed. The active IND enables Xeris to initiate a Phase 1 clinical study for XP-8121 using its novel formulation of levothyroxine in a subcutaneous injection for the treatment of hypothyroidism. The Phase 1 study will characterize Pharmacokinetics (PK) and evaluate the safety and tolerability of XP-8121 in healthy participants.

"Levothyroxine is one of the most widely prescribed drug products in the United States. However, due to the many challenges associated with oral formulations there remains an area of significant unmet need. We believe that a potentially weekly subcutaneous injection of XeriSol levothyroxine can mitigate many of these challenges and improve compliance. The Phase 1 study is the first step toward addressing this unmet need," said Kenneth E. Johnson, PharmD, Xeris Senior Vice President of Global Development and Medical Affairs.

"The FDA acceptance of our XP-8121 further underscores the applicability of our XeriSol technology and progress of our pipeline. We will continue to invest in our pipeline in therapeutic areas where we have an established commercial footprint," said Paul R. Edick, Chairman and CEO of Xeris.

About Levothyroxine and Hypothyroidism

The thyroid gland is responsible for the synthesis, storage, and release of metabolic hormones including thyroxine (T4) and triiodothyronine (T3) [Colucci et al, 2013]. These hormones are crucial in the regulation of critical metabolic processes and are vital for normal growth and development during fetal life, infancy, and childhood.

Story continues

Therapeutically, levothyroxine is administered when the body is deficient in the endogenous hormone. The goal of therapy is restoration of the euthyroid state which can reverse the clinical manifestations of hypothyroidism and significantly improve quality of life [Winther et al, 2016]. The treatment of choice for correction of hypothyroidism is levothyroxine, which is the mainstay of thyroid hormone replacement therapy. It is one of the most widely prescribed drug products in the United States, but the complexity of maintaining biochemical and clinical euthyroidism in patients undergoing treatment with oral levothyroxine cannot be underestimated. It has been reported that nearly 40% of patients undergoing treatment with oral levothyroxine are either over- or under-treated [Laurent et al, 2018] due to factors that include, but are not limited to, drug formulation, use of the drug with food, adherence to the drug, use of concomitant medications, and pre-existing medical conditions. Many patients failing to reach target TSH levels are generally managed by simply increasing their levothyroxine daily dose [Chiovato et al, 2019]. However, levothyroxine is a drug with a narrow therapeutic index [Vita et al, 2014], meaning that relatively small deviations from the proper dose can cause a clinically meaningful shift in pharmacological effects when administered to a patient; thus, the titration of levothyroxine oral drug may be a tailored and incremental process.

About Xeris Pharmaceuticals, Inc.

Xeris (Nasdaq: XERS) is a pharmaceutical company delivering innovative solutions to simplify the experience of administering important therapies that people rely on every day around the world.

With a novel technology platform that enables ready-to-use, room-temperature stable formulations of injectable, the company is advancing a portfolio of solutions in various therapeutic categories, including its first commercial product, Gvoke in the U.S. Its proprietary XeriSol and XeriJect formulation technologies have the potential to offer distinct advantages over conventional product formulations, including eliminating the need for reconstitution, enabling long-term, room-temperature stability, significantly reducing injection volume, and eliminating the requirement for intravenous (IV) infusion. With Xeris technology, new product formulations are designed to be easier to use by patients, caregivers, and health practitioners and help reduce costs for payers and the healthcare system.

Xeris is headquartered in Chicago, IL. For more information, visit http://www.xerispharma.com, or follow us on Twitter, LinkedIn or Instagram.

Forward-Looking Statements

Any statements in this press release about future expectations, plans and prospects for Xeris Pharmaceuticals, Inc., including statements regarding the market and therapeutic potential of its products and product candidates, expectations regarding clinical data or results from planned clinical trials, the timing or likelihood of regulatory approval and commercialization of its product candidates, the timing and likelihood of the consummation of the Strongbridge Biopharma acquisition, the timing or likelihood of expansion into additional markets, the timing or likelihood of identifying potential development and commercialization partnerships, the potential utility of its formulation platforms and other statements containing the words "will," "would," "continue," and similar expressions, constitute forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including, without limitation, the impact of COVID-19 on its business operations, its reliance on third-party suppliers for Gvoke and Ogluo, the regulatory approval of its product candidates, its ability to market and sell its products, if approved, and other factors discussed in the "Risk Factors" section of the most recently filed Quarterly Report on Form 10-Q filed with the United States Securities and Exchange Commission (the "SEC"), as well as discussions of potential risks, uncertainties, and other important factors in Xeris subsequent filings with the SEC. Any forward-looking statements contained in this press release speak only as of the date hereof, and Xeris expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.

The Company intends to use the investor relations portion of its website as a means of disclosing material non-public information and for complying with disclosure obligations under Regulation FD.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210811005814/en/

Contacts

Investor Contact Allison WeySenior Vice President, Investor Relations and Corporate Communicationsawey@xerispharma.com 312-736-1237

Read more:
Xeris Pharmaceuticals Announces FDA Acceptance of its IND Application for XeriSol Levothyroxine (XP-8121) for the Treatment of Hypothyroidism - Yahoo...

Posted in Hormone Replacement Therapy | Comments Off on Xeris Pharmaceuticals Announces FDA Acceptance of its IND Application for XeriSol Levothyroxine (XP-8121) for the Treatment of Hypothyroidism – Yahoo…

My bosses were happy to destroy me the women forced out of work by menopause – The Guardian

Posted: August 18, 2021 at 2:37 am

In 2019, Maras weekly performance review meetings grew intolerable; she would sit in a cramped conference room with her supervisors only to be told that she wasnt performing well enough. I felt like a child, says Mara, who is 48, lives in Hampshire and works and works as a public servant. They would tell me off. Theyd say: You wont meet this deadline, will you? You didnt put a paragraph in this document.

A year earlier, Mara had had a hysterectomy, to alleviate her endometriosis. Afterwards, in surgically induced menopause, she began to experience debilitating brain fog, anxiety and depression. I was drowning, she says. I was overwhelmed. I couldnt see or think. Doctors prescribed antidepressants and oestrogen gel, but nothing helped. Mara could barely function at work. I couldnt retain anything, she says. I had no memory. I couldnt see or think clearly enough to do my work. I had no confidence at all. I thought I was useless.

Mara told her supervisors she had depression and anxiety, and submitted a doctors note, but they put her on a first warning. At the time she didnt realise her depression was linked to the menopause - all she knew was that she needed help. (In the autumn of 2019, a specialist explained that her symptoms were caused by the menopause, and provided her with a doctors note explaining this to her employers, but they continued to monitor her performance, as theyd done previously.)

Every week, she had to attend a meeting with her supervisors, where theyd tell her that, once again, she had failed to meet the standard expected. By the summer of 2019, Mara couldnt cope any more.

That weekend, she spent a sunny afternoon with her husband and son at a local fair. The following day, she woke up and drove to a nearby motorway bridge. She sat on a patch of grass and ignored the fact her phone was vibrating with texts from her concerned husband. Instead, she spent a few hours assessing what she felt, then, were her options. It wasnt that I wanted to die, she says. I needed to die. Work wasnt ever going to stop doing what they were doing to me. And I was so ashamed to be so incompetent at my job.

She stood up and approached the bridge, feeling completely empty. She peered over the side, then realised, to her dismay, that the bridge wasnt high enough. I thought, she says, if I jump, I will survive. And there was no way I wanted to survive. And that is the only reason I am alive today. Because it wasnt high enough.

Maras story is an extreme example of the devastating impact the menopause can have on womens jobs and their mental and physical health. Its really difficult to collect data on how many women may be leaving the workplace due to the menopause, says Dr Vanessa Beck, an expert in work and organisation at the University of Bristol, because its not something people tend to talk about in exit interviews. Even if women were asked about the menopause when leaving companies, Beck isnt sure it would help. Im not convinced that women would disclose, she says. Theres a lot of shame.

Some data does exist, however. A 2019 survey from Bupa and the Chartered Institute of Personnel and Development (CIPD) found that 59% of working women aged 45 to 55 who were experiencing the menopause reported that it had a negative impact on them at work, with the most common issues including a reduced ability to concentrate, and feeling more stressed and less patient with clients and colleagues. The same survey estimated that 900,000 women had so far left their jobs, due to menopausal symptoms.

Meanwhile, a survey of 1,132 women from Newson Health Menopause and Wellbeing Centre, also published in 2019, found that over 90% of respondents felt that menopausal or perimenopausal symptoms were affecting their performance at work, and one-third of women had considered reducing their working hours or even leaving their job as a result. Also, earlier this month, the Guardian reported on the growing number of women taking their employers to tribunal, claiming unfair dismissal and sex discrimination due to their experience of the menopause.

In July, the House of Commons women and equalities committee launched an inquiry into menopause and the workplace. These are women in the prime of their lives, says the committees chair, Caroline Nokes MP, in their late 40s and 50s, who should be in senior positions ... These are the people who should be the trailblazers and role models for younger people in the workplace.

Almost uniformly, women experiencing menopausal symptoms at work struggle to talk openly about it. Quite simply, its embarrassing. Theres a stigma around it, says Rachel Weiss, founder of The Menopause Cafe, a safe space where men and women can gather to talk about the menopause. Being an older woman is not viewed as a positive thing in our society.

It is not hard to see why many women would not want to disclose that they are menopausal or perimenopausal at work. Menopausal women are too often represented as figures of fun, to be excoriated or mocked. I remember a senior civil servant using the term menopausal as if it was some kind of insult, says Nokes. You wouldnt be able to discriminate against black or gay people in that way and use their status and who they are as an insult. But it is seen as OK when were talking about women of a certain age.

Using the word as a slur can create a toxic working environment for women. Every little mistake I made, says Sukie Stratton, a 51-year-old insurance investigator from Gloucestershire, people would say: Oh, you must be in the menopause. That was during her short stint in 2019 as a trainee police officer (not for Gloucestershire police).

She realised early on that her age might be a problem. One of my trainers came up to me, Stratton remembers, and said: I am worried about you, because youre in your late 40s. You wont be able to do the night shift. I said: Why not? She said: Because youll be menopausal, wont you? You wont be sleeping and youll be tired all the time.

Even though Stratton did not even have menopausal symptoms, the comments were constant. When her colleagues saw her sweating in her cumbersome body armour, they would make jibes about hot flushes. If she made a minor mistake, they would assume it was memory loss. One of the final straws was when a relief sergeant referred to Stratton as a bloody knackered menopausal woman in front of an office full of her peers.

Stratton emailed HR, but she says they didnt respond to her emails. One morning, she was on patrol. It was 4am, and she was sitting in the van, talking to a trusted colleague. She confided in him. He told her, candidly: This is how it is. You will never get anywhere, she remembers. Stratton realised he was right. All the women her age had been moved to desk jobs, or sent to rural offices with little chance of promotion. She handed in her notice.

I felt massive disappointment, she says. Because Id always wanted to join the police, and Id held the police in high regard. I couldnt understand why theyd dismiss someone who was capable. They seemed to think that being menopausal meant that I wasnt up to the job.

Not all women, of course, are driven out by such rank discrimination. Others, including Mara, leave because they feel unsupported by employers. But a third cohort of women leave because the very thought of disclosing their menopausal status to their employers is too horrifying to consider.

Cara, who is 46 and lives in Wiltshire, walked away from her job in higher education in November 2020 due to the perimenopause. I wasnt actively forced out, Cara says, but I didnt feel like I had any choice, or options. Cara had low mood, brain fog, muscle and joint pain. Id find it hard to concentrate on stuff I would be sailing through normally, she says. Worst of all was the loss of sleep. There would be some nights where I would get no sleep, she says. A good night would be four hours.

Cara handed in her notice because she felt unable to perform at the level she had previously. I wasnt giving my best, she says. I felt isolated and embarrassed and I didnt want to get to a point where my job did suffer, and someone would say something. I felt I wasnt able to do the job I had done for all those years at the same level. I ask Cara why she didnt ask her employers for extra support. I felt ashamed, is the reply.

This self-enforced silence is common among the women who attend Weisss menopause cafes. What we find, she says, is that a lot of women arent talking to anyone else about their menopause symptoms. They wonder if theyre going mad, or if theres something wrong with them. Women may feel mortified by some symptoms such as menstrual flooding (very heavy bleeding), and feel that it is easier to quit than endure the mortification of explaining to their supervisors why they cant be more than a few metres from a toilet.

Physically, says Dr Helen Douglas, 49, from Glenshee in the Scottish Highlands, I didnt feel well enough to stand on my feet all day. Douglas went into surgical menopause in 2013, aged 41, after a hysterectomy for endometriosis and uterine fibroids. At the time, she managed a forensic laboratory. It was stressful, she says. The sort of job where you need attention to detail.

Afterwards, Douglass stomach was swollen, making it impossible to get into her clothes, and she had persistent bleeding. Mentally, she wasnt doing well. I wasnt sleeping, she says. I had anxiety and my hands would shake. Memory issues. I was short-tempered and irritable. I just wanted to tell everyone where to go. If someone cancelled a meeting at short notice, Douglas would internalise the anger until it led to a panic attack, she says.

She had suffered from depression in the past, and at the time, she didnt realise her symptoms were menopause-related. I thought it was just a bad episode of depression again, Douglas says. She resigned in 2014. I couldnt do it any more, she says. Id been having recurrent thoughts of ending my life.

Yet the outlook for women approaching the menopause in the workplace is not totally bleak. The stigma is abating. Over the last year or so women have been much more open about it than ever before, says Nokes. Women like Davina McCall [who recently made a documentary on the subject for Channel 4] have spoken about their own experiences honestly.

Nokes is willing to practise what she preaches. I am prepared to say I think I probably am perimenopausal, she says. I have horrific night sweats. She recently had to alter the bedding she uses. Ive got the thinnest duvet on my bed ever, Nokes says. But at least Im not waking up at 3am, dripping in sweat.

Many believe the NHS needs to improve its offering to menopausal women. We need a multidisciplinary team to look after women after the menopause, says Douglas. Rather than seeing it as a gynaecological issue, women should be referred to someone who has a handle on the mental health side of things.

Mara believes GPs could also do with better training: it was only through reading menopause support forums online that she learned about a drug called utrogestan, a form of hormone replacement therapy. I rang my doctor, she says, and she prescribed it, and literally overnight I started feeling better. My husband noticed within 48 hours. He said: Are you on new medication? Youve turned nice again.

Another obvious solution would be menopause-friendly workplaces. Douglas advocates for companies to have specific policies around it. It would be really helpful if there was a menopause-in-the-workplace champion, she says, someone women knew they could go to. Simple adjustments switching uniforms from synthetic fibres to natural fabrics. Having free and frequent access to bathrooms, in case women are flooding.

Some employers are ahead on this. The water company Severn Trent was the first UK employer to specifically introduce a menopause policy. The CIPD has subsequently published guidance for employers on addressing the menopause at work, while last year the Wales TUC published a toolkit.

Deborah Garlick of the training provider Menopause in the Workplace began offering menopause training to employers in 2016. We organised our first menopause in the workplace conference, says Garlick, and people thought we were bonkers. But then some very large employers said, Why didnt we know this? And thats how we got started.

Part of the select committees forthcoming work will be to evaluate whether UK discrimination law is fit for purpose on the menopause. Do we need to make menopause a protected characteristic, in the same way that maternity leave currently is? asks Nokes.

Under existing law, menopausal women are protected because age, sex and disability are protected characteristics under the 2010 Equality Act. But because menopause is not specifically protected, women have to pick the characteristic they want to take a case under, Beck says.

Nokes says she is open-minded about introducing such legislation. This is impacting 50% of the population, Nokes says, and its pushing them out of the workplace. So maybe it should be a protected characteristic. Regardless of whether or not legislation is introduced, Beck urges employers to make adjustments for older women. Theres the business case, she says. Its costly to replace an experienced worker. But its about more than that its the right thing to do. If you are a good employer, you should want to support your workers.

The hope is that, with time, more enlightened employers, and government intervention if necessary, no woman should ever have to go through what Mara endured. I was a person with value, and they were happy to destroy me and get rid of me, because of the menopause, Mara says. Thankfully, with the help of medication, her symptoms have abated. My energy levels are a bit low, she says, but Im almost there.

After five years out of the workforce, living on savings and focusing on her mental health, Douglas, likewise, has found a new vocation, as a writer and menopause awareness activist. I dont regret leaving my old job, she says thoughtfully. Its taken a lot of time and work to get to a place where I am comfortable saying that. But what I do now can make a positive difference. Its more satisfying.

Some names have been changed.

In the UK and Ireland, Samaritans can be contacted on 116 123 or by emailing jo@samaritans.org or jo@samaritans.ie. In the US, the National Suicide Prevention Lifeline is 1-800-273-8255. In Australia, the crisis support service Lifeline is 13 11 14. Other international helplines can be found at befrienders.org.

Read the original:
My bosses were happy to destroy me the women forced out of work by menopause - The Guardian

Posted in Hormone Replacement Therapy | Comments Off on My bosses were happy to destroy me the women forced out of work by menopause – The Guardian

I worry that men won’t find me attractive if I get my breasts removed – Metro.co.uk

Posted: August 18, 2021 at 2:37 am

My breasts are not huge, but theyre undeniably there (Picture: Shutterstock / nito)

When I close my eyes, I imagine myself with a flat chest and the scars from top surgery still visible and I feel strength and power of being my best, truest self.

However, when I open them, I see a chest that is anything but flat. Im looking at a body with hips and curves and breasts that are partially hidden by a 34G bralette.

Although I want top surgery,as abisexualtransgender man, Im anxious that men wont find me attractive if I get a subcutaneous mastectomy the medical term for the procedure.

I have a huge amount of dysphoria, which is defined by theGender Identity Clinic(GIC) as the distress experienced by those whose gender identity feels at odds with aspects of their body and/or the social gender role assigned to them at birth.

I experience it most acutely around my breasts, struggling daily with the disconnect between how my body looks in my head and how it looks in the mirror.

Its not the clich of having been born in the wrong body so much as people assuming that everyone with a body like mine must be a woman. The discomfort is sharp and painful and reverberates through me: everything feels wrong.

Its been 18 months since I began the process of socially transitioning: coming out to the people around me as trans, asking people to respect my pronouns, and changing the way I present to the world.

Even before I had fully acknowledged my own transness and that I wasnt cisgender (meaning my gender identity is not the same as the gender I was assigned at birth when a doctor looked at my genitals) I had begun to think about the kind of medical transition I wanted.

Stepping into my gender has shown me how important pursuing hormone replacement therapy (HRT) and surgery are for me.

My breasts are not huge, but theyre undeniably there. I dont remember when they developed, because for most of my childhood and teenage years, I was scared of my body and ignored it as much as possible.

Some days it feels like my whole body is shouting its wrongness at me until I want to cry. Yet even as I came out to my GP and asked for a referral to a Gender Identity Clinic, a tiny part of my brain worried at how getting top surgery would change the way people saw me.

Strangers will be more likely to see me as a man after top surgery of course, which is what I want. It can be incredibly painful to go through life being misgendered, and sometimes the thought that people see a woman when they look at me makes me want to tear my skin off. The three to five year waiting list for surgery feels interminable.

So why does a small part of me care that I might be less attractive if I have the gender affirming surgery that it often feels like my whole body is yearning for?

I am already a man, albeit one with breasts that I often forget I have

The answer, while not pretty, is simple: its because Ive spent my whole life being tolda cisnormative (the harmful assumption that everyone is cisgender), heteropatriarchal society both indirectly and explicitly that my worth is based on my desirability to straight, cisgender men. It feels deeply unfeminist and a betrayal of my own queer identity to admit that.

As a bisexual trans guy, I have no interest in sleeping with straight, cis men yet the need to centre their desire persists.

As someone whose body is automatically sexualisedby men who feel entitled to it, with or without my consent, Ive learned to reclaim that.

I feel so powerless when I am cat-called in the street. Theres fear, yes, but theres also shame that twists red-hot inside me when a group of laughing men shout are you legal yet? after me as I walk away with my whole body shaking.

I know that men are attracted to my breasts though Ive experienced more sexual harassment while wearing shorts or crop tops so I find it empowering to pick out tight or low-cut tops to emphasise my breasts.

Even now, dressing in ways that show off my cleavage can still feel good: owning my sexuality feels powerful because it is something that society has told me to be ashamed of.

When I have top surgery, I can imagine myself standing taller. Not because Im free from the sexualisation of being a person with breasts, but because I will have made my body undeniably mine in a way that feels like a raised middle finger to that shame. Its a rejection of who I should be for who I really am.

I dont want to take testosterone or have top surgery to become a man. I am already a man, albeit one with breasts that I often forget I have. I want top surgery because I want my body to feel right in the way the rest of me does since stepping into my transness, yet I still trip up over the anxiety that men will no longer find me attractive without my breasts.

That anxiety shows that as much as Ive spent the last six years immersing myself in queer and feminist culture, I still have the flawed yet fundamental belief that my worth is based in how much straight, cis men want to have sex with me.

I hate how much I believe that lie. It horrifies me that I dont even want to have sex with straight, cis men yet I still cant seem to shake it. How many choices must women (and other people affected by misogyny) make every day because weve been conditioned that our own wants should be secondary?

We can reframe getting nails done as self-care and we can find that wearing high heels gives us confidence even though they hurt our feet, but those choices are not independent of patriarchal repercussions.

Adjusting everything from our behaviour to our breasts is the price we pay for being taken seriously in a society that revolves around the axis of straight, cis mens desire. And when were still punished for not falling in line with the male gaze, it becomes even harder to de-centre that desire and stand steady in our own self-worth.

Despite how inaccessible gender-affirming healthcare is, truly internalising the belief that I have value beyond my desirability might actually be harder. Even when not if I get top surgery, thats something that Im going to have to keep working on.

Do you have a story youd like to share? Get in touch by emailing James.Besanvalle@metro.co.uk.

Share your views in the comments below.

MORE : Transgender man faces gruelling body dysphoria and is desperate for top surgery

MORE : Coming out as transgender during lockdown feels like Im in limbo

MORE : Elliot Page says undergoing top surgery as part of transgender journey has been life changing and lifesaving

Original post:
I worry that men won't find me attractive if I get my breasts removed - Metro.co.uk

Posted in Hormone Replacement Therapy | Comments Off on I worry that men won’t find me attractive if I get my breasts removed – Metro.co.uk

BioRestorative Therapies Discusses Upcoming Annual Meeting – GlobeNewswire

Posted: August 18, 2021 at 2:35 am

MELVILLE, N.Y., Aug. 11, 2021 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the Company or BioRestorative) (OTC: BRTX), a life sciences company focused on stem cell-based therapies, today reminded its stockholders that its annual meeting of stockholders will be held on Tuesday, August 17, 2021 at 10 a.m. EDT.

Lance Alstodt, President and Chief Executive Officer of the Company, stated At the stockholders meeting, certain proposals, including the approval of our reincorporation from Delaware to Nevada or, in the alternative, the authorization of a reverse split of our common stock will be submitted for a vote of the stockholders. These matters are discussed in the proxy materials mailed or made available to BioRestorative stockholders by Broadridge Financial Solutions.

We cannot complete the reincorporation or reverse split unless the holders of a majority of the outstanding shares of common stock entitled to vote approve the proposal.

If you are a stockholder of record as of June 24, 2021, we ask you to take a moment to vote your shares online at Proxyvote.com.

We appreciate your continued support.

About BioRestorative Therapies, Inc.

BioRestorative Therapies, Inc. (www.biorestorative.com) develops therapeutic products using cell and tissue protocols, primarily involving adult stem cells. Our two core programs, as described below, relate to the treatment of disc/spine disease and metabolic disorders:

Disc/Spine Program (brtxDISC): Our lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a persons own) cultured mesenchymal stem cells collected from the patients bone marrow. We intend that the product will be used for the non-surgical treatment of painful lumbosacral disc disorders or as a complementary therapeutic to a surgical procedure. The BRTX-100 production process utilizes proprietary technology and involves collecting a patients bone marrow, isolating and culturing stem cells from the bone marrow and cryopreserving the cells. In an outpatient procedure, BRTX-100 is to be injected by a physician into the patients damaged disc. The treatment is intended for patients whose pain has not been alleviated by non-invasive procedures and who potentially face the prospect of surgery. We have received authorization from the Food and Drug Administration to commence a Phase 2 clinical trial using BRTX-100 to treat chronic lower back pain arising from degenerative disc disease.

Metabolic Program (ThermoStem): We are developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells to generate brown adipose tissue (BAT). BAT is intended to mimic naturally occurring brown adipose depots that regulate metabolic homeostasis in humans. Initial preclinical research indicates that increased amounts of brown fat in animals may be responsible for additional caloric burning as well as reduced glucose and lipid levels. Researchers have found that people with higher levels of brown fat may have a reduced risk for obesity and diabetes.

Forward-Looking Statements

Certain statements in this communication may constitute forward-looking statements that reflect managements current views with respect to future events and financial performance. Forward-looking statements are projections in respect of future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as may, should, expects, plans, anticipates, believes, estimates, predicts, potential or continue or the negative of these terms or other comparable terminology. These statements include statements regarding the intent, belief or current expectations of us and members of our management team, as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risk and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. These statements are only predictions and involve known and unknown risks, uncertainties and other factors, including the risks set forth in the section entitled Risk Factors in our Annual Report on Form 10-K for the fiscal year ended December 31, 2020, as filed with the SEC on April 30, 2021, and our Quarterly Report on Form 10-Q for the quarter ended March 31, 2021, as filed with the SEC on May 17, 2021, any of which may cause the Companys or our industrys actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied in our forward-looking statements. These risks and factors include, by way of example and without limitation:

Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, or performance. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

Readers are urged to carefully review and consider the various disclosures made by us in this communication and in our reports filed with the SEC. We undertake no obligation to update or revise forward-looking statements to reflect changed assumptions, the occurrence of unanticipated events, or changes in the future operating results over time, except as required by law. We believe that our assumptions are based upon reasonable data derived from and known about our business and operations. No assurances are made that actual results of operations or the results of our future activities will not differ materially from our assumptions.

CONTACT:Email: ir@biorestorative.com

Read more here:
BioRestorative Therapies Discusses Upcoming Annual Meeting - GlobeNewswire

Posted in Nevada Stem Cells | Comments Off on BioRestorative Therapies Discusses Upcoming Annual Meeting – GlobeNewswire

Women in Health: Its all in the genes for Prof Michle Ramsay – Daily Maverick

Posted: August 18, 2021 at 2:31 am

Professor Michle Ramsay, Professor of Human Genetics and the director of the Sydney Brenner Institute for Molecular Bioscience at Wits University. (Photo: Supplied / Spotlight)

As a child, South Africas Prof Michle Ramsay never dreamt of a future in academia or receiving an Oscar in Science. Instead, she was interested in climbing trees and pretending they were spaceships.

By the time she started her first year at the University of Stellenbosch, Ramsay had lived in four countries South Africa (Vereeniging), Mexico, Canada and the United Kingdom. Her father was an engineer and the family followed him to where his work took him. It is these experiences that gave Ramsay valuable insight into the diversity of people and which shaped her worldview.

Today, Ramsay is a professor of human genetics and director of the Sydney Brenner Institute for Molecular Bioscience at Wits University. Last year, Ramsay won the National Science and Technology Forum-South32 Lifetime Achievement Award for pioneering genomic medicine approaches in Africa, and for leading a transcontinental study to search for factors that contribute to diseases among people living on the African continent. The awards are dubbed the Oscars of Science.

Genetics: A passion is born

Well, I can definitely tell you, I never dreamt of being an academic, says Ramsay. That came much later. I did enjoy biology at school, but my real interest started when I got to university and had my first exposure to the field of genetics. After three lectures, I knew this was what I wanted to do.

At that stage, it didnt matter to me if it was human, plant or animal genetics. Inheritance patterns were so logical and interesting.

Although being an academic was never part of her plan, she now heads a research institute building knowledge on African genomic diversity and providing clues for genetic susceptibility to many diseases.

Ramsay says the best part of her journey has been growing alongside a new field of knowledge molecular genetics. When I started, so little was known about the human genome. It was unthinkable that we could look at a persons DNA and make a diagnosis for a disease or perform a prenatal diagnosis where we could diagnose babies in utero to see if they inherited a genetic disease from their parents.

I feel that I have been so fortunate in my career to have experienced all these changes and to work in a field that is in its heyday right now.

Ramsay says for years they have been working in labs on the human genome and now, with Covid-19, the field of genomics has become popular since everyone is talking about it.

Before joining a Zoom meeting with Spotlight, she was at another meeting where they are planning the third international summit on human genome editing. Genome editing involves changing an organisms DNA using new technologies.

There have been huge strides in the field and it is extraordinary that the scientific community is developing technologies to edit genomes. There are so many ethical issues for the field, in addition to the scientific challenges. We ask many questions, such as should it be done, is it safe, will there be equity in terms of access and affordability? [There are] so many things to think about, she says.

We felt like pioneers

Ramsay says that when she finished her postdoctoral fellowship in London in 1989, she had the option to stay there. But I wanted to come back to South Africa. I knew I could make a meaningful contribution in my country and Im happy that I came back, she says.

Ramsay was part of a team that set up a DNA diagnostic laboratory for genetic diseases in South Africa in 1980.

We felt like pioneers. The techniques were very new and we had to teach ourselves and learn as we went along, she says. A three-month student exchange visit to the Weizmann Institute of Science in Israel at that time was a huge help. It was an interesting time because we had to put everything together for our experiments, she says, adding that there were no kits and very little expertise. They had to develop reagents and plan experiments, putting all the components together.

One of the highlights of my career was setting up the molecular diagnostic laboratory to do the first prenatal diagnosis by DNA analysis in South Africa. We published this in 1984, not long after the methods had first been applied elsewhere in the world. It was good to know that we could do in South Africa what was at the forefront elsewhere in the world, she says.

Research for the future

Her interest has now turned to understanding interactions between genetic variations and the environment.

In terms of the health of a person, this is really a difficult thing to study because there are endless combinations, and trying to understand what is relevant and important is not so easy, she tells Spotlight.

Another area of research at our institute is to understand how people respond to drugs. For example, if there are 100 people with hypertension, some will respond to one drug and normalise their blood pressure, but for other people, that drug wont work and doctors need to try another drug. It is often a trial-and-error process. What do you start off with first? But, if you understand the genetics behind the drug response, that can often help a doctor find the right drug quicker for their individual patients, she says.

This is what we would like to be able to do in the future. We would be developing this field that we call precision medicine and it will be appropriate for Africans because we are doing the research here. It is about having enough information about a patient to help a doctor get to the right treatment at the right time in a much shorter period.

Covid-19 and the host

Another thing that interests her is the role of the genome of the host following SARS-CoV-2 infection. She explains that the person who becomes infected by the virus is the host. The viral genome is being studied, but few people are looking at the host genome.

What we do know is that when the virus infects the host, the response is different between people. The large majority of people dont even know that they are infected. Some may have a cough or an elevated temperature for a while and they go on with life. Then there are others who have to go to hospital. Some of them will get oxygen, take a week to recover, and go home. [Others] get progressively more ill, needing a ventilator, and some of them die.

Trying to understand why this happens is fascinating. We have started a project to explore the genetic contribution of the host and why some people are more likely to become severely ill, she says.

If you knew who is more likely to become severely ill, doctors could start treatment much sooner and have better outcomes. There are groups all over the world doing this research, but it hasnt been done on Africans (people living on the African continent). This is the focus of our work.

But of course, Africa is not homogenous. Its a very complex continent of people with different genetic backgrounds and different environments, she says, adding that because Africa is the cradle of humankind, there is more genetic variation in the people of Africa than anywhere else in the world, yet it is understudied.

Living through Covid-19

As with most people, the pandemic forced Ramsay to shift into a lower gear and slow down.

The things that are important to me during this time are the small things, like walking in my garden. I remember when we had the first hard lockdown, how I watched the strelitzias every day as the buds slowly opened up into magnificent flowers. This is amazingly uplifting, she says. I didnt do that before because I was always rushing off to work and rushing back again, often after dark. I think the pandemic has made me appreciate many joyful small things in life.

Among her reading stack is The Promised Land by former US president Barack Obama, which she picks up in between other books.

I find it a fascinating read. The things he had to overcome during his presidency, and the challenges that he faced. We all face challenges and its up to us how we deal with them. What I enjoy is working with people who are willing to learn and to think about making [a] positive change. It is exhausting when people only see the problems, she says.

The proud mother of two says her son just completed his PhD as a chemical engineer and her daughter is an intern medical doctor.

As a career woman and a mother, you always feel that you put so much into your work and professional life and that you may have neglected your kids from time to time. I am glad my children seem none the worse for it and I am happy that they have careers of their own ahead of them, she says, adding that she is also blessed with a husband who is a good listener and has always supported her.

Ramsay says she also took up knitting and is now making a Covid blanket.

The blanket will be a reminder of these challenging times for us in years to come and something to tell our grandchildren about one day. We are having Zoom meetings all the time and when Im not presenting or taking notes, I actually knit. I find I concentrate better when my hands are busy, she says.

The secret to knitting, Ramsay says, is to find big needles and beautiful wool colours. DM/MC

This article is part of Spotlights Women in Health series featuring the remarkable contributions of South African women to medicine and science.

This article was produced by Spotlight health journalism in the public interest.

View post:
Women in Health: Its all in the genes for Prof Michle Ramsay - Daily Maverick

Posted in Molecular Genetics | Comments Off on Women in Health: Its all in the genes for Prof Michle Ramsay – Daily Maverick

UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer – University of Virginia

Posted: August 18, 2021 at 2:31 am

A drug used to treat certain advanced breast cancers may offer a new treatment option for a deadly blood cancer known as myelofibrosis, new research from UVA Cancer Center suggests.

The drug, palbociclib, may be able to prevent the scarring of bone marrow that existing treatments for myelofibrosis cannot. This scarring disrupts the marrows production of blood cells and causes severe anemia that leaves patients weak and fatigued. The scarring also reduces the number of platelets in the blood, making clotting difficult, and often causes an enlarged spleen.

Current therapies only provide symptomatic relief without offering significant improvement of bone marrow fibrosis. So, there is a critical need to develop more effective therapy for myelofibrosis, said senior researcher Golam Mohi of the University of Virginia School of Medicines Department of Biochemistry and Molecular Genetics. We have identified CDK6, a regulator of cell cycle, as a new therapeutic target in myelofibrosis. We demonstrate that CDK4/6 inhibitor palbociclib, in combination with ruxolitinib, markedly inhibits myelofibrosis, suggesting this drug combination could be an effective therapeutic strategy against this devastating blood disorder.

Myelofibrosis is a form of leukemia. It occurs in approximately 1 to 1.5 of every 100,000 people, primarily those who are middle-aged or older. Patients with intermediate or high-risk cases typically survive only 16 to 35 months.

Existing treatments for myelofibrosis do not address the bone marrow scarring that is a hallmark of the disease. The drug ruxolitinib is used to relieve patients symptoms, but Mohis new research suggests that pairing the drug with palbociclib may make a far superior treatment.

Palbociclib, by itself, reduced bone marrow scarring in two different mouse models of myelofibrosis. It also decreased the abnormally high levels of white blood cells seen in myelofibrosis and shrank the mices enlarged spleens.

Combining the drug with ruxolitinib offered even more benefits, restoring the bone marrow and white blood cell counts to normal and dramatically reducing the size of the mices enlarged spleens.

Additional research is needed to determine if the findings will hold true in human patients, but Mohi and his team are hopeful. They note that palbociclib is known to quiet the activity of bone marrow in patients with metastatic breast cancer (cancer that has spread to other parts of the body), and they hope there will be beneficial effects in patients with myelofibrosis.

A combinatorial therapeutic approach involving palbociclib and ruxolitinib will enable lowering the doses of each of the inhibitors and thus reducing toxicities while enhancing the therapeutic efficacy, they write in a new scientific paper outlining their findings.

New treatments for myelofibrosis are particularly needed because ruxolitinib treatment does not offer significant reduction in bone marrow fibrosis and often loses its effectiveness with prolonged use, the researchers note.

The findings from this study are very exciting, and they support the clinical investigation of palbociclib and ruxolitinib combination in patients with myelofibrosis, Mohi said.

Mohi and his team havepublished their findings in the journal Cancer Research. The research team consisted of Avik Dutta, Dipmoy Nath, Yue Yang, Bao T. Le and Golam Mohi.

The work was supported by the National Institutes of Health grants R01 HL095685, R01 HL149893 and R21 CA235472.

To keep up with the latest medical research news from UVA, subscribe to theMaking of Medicineblog.

See the article here:
UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer - University of Virginia

Posted in Molecular Genetics | Comments Off on UVA Discovery Suggests Potential New Treatment for Deadly Blood Cancer – University of Virginia

Immunicom Continues Successful Immunopheresis Clinical Trial in Advanced, Non-Small Cell Lung Cancer Treatment with Acibadem University – Business…

Posted: August 18, 2021 at 2:30 am

SAN DIEGO & ISTANBUL--(BUSINESS WIRE)--Immunicom, Inc., a clinical stage biotech pioneering non-pharmaceutical immunotherapies, progresses with its cancer clinical trial to evaluate the clinical effectiveness of Immunopheresis in partnership with Acibadem University conducted in Acibadem Healthcare Group hospitals. This multi-arm study has been recruiting patients since October 2020 and evaluates Immunicoms oncology platform for non-small cell lung cancer (NSCLC) in combination with Roches pharmaceutical checkpoint inhibitor, Tecentriq (atezolizumab). This is Immunicoms third clinical trial assessing Immunopheresis for solid cancers.

The Immunopheresis therapy employs Immunicoms lead product, the proprietary LW-02 subtractive column, to remove targeted immune-suppressive cytokines that block the natural immune response to attack malignant tumors. Immunopheresis is intended to treat cancer while avoiding the typical side-effects, toxicity, and negative impacts on quality of life that are frequently associated with other cancer treatments.

Immunicoms LW-02 column has received U.S. FDA Breakthrough Device designation for stage IV metastatic cancer and has received European regulatory clearance (CE Mark certification) for use in adults with advanced, refractory, triple negative breast cancer (TNBC).

Lung cancer is one of the most common cancers in the world and the most prevalent cancer in Turkey. Currently available therapies for lung cancer are commonly associated with serious side-effects and often patients tumors become resistant to even the newer immunotherapies. Moreover, the presently available immunotherapies are prohibitively expensive which precludes this option for many patients, said Ahmet ahin, MD., Prof., Chairman of the Medical Executive Board of Acibadem Healthcare Group. We are highly optimistic that Immunicoms Immunopheresis therapy will provide physicians with a novel breakthrough cancer immunotherapy that should be markedly better tolerated, improve patients quality of life, and its cost-effectiveness will make it widely available to many patients who might otherwise not be able to benefit from an immunotherapy.

The multicenter, multi-arm clinical study led by Gkhan Demir, MD, Prof., Acibadem University School of Medicine, Department of Internal Diseases Medical Oncology who serves as the Principal Investigator, and conducted by Mustafa Bozkurt, MD tests the clinical effectiveness of the LW-02 Immunopheresis column to treat stage IIIB/IV non-small cell lung cancer patients whose disease has progressed after at least one first-line chemotherapy round of treatment. The clinical study is divided into three treatment arms, each with the LW-02 column; the first in combination with Tecentriq (atezolizumab), the second in combination with Taxol (paclitaxel), and the third with Immunopheresis as a monotherapy for patients who have disease progression after a second-line of chemotherapy treatment.

With this clinical trial, Immunicom and Acibadem are centered on demonstrating the effectiveness of Immunicoms Immunopheresis therapy for treating patients facing a highly aggressive form of non-small cell lung cancer. This important study assesses Immunopheresis in combination with both Roches Tecentriq, one of the worlds leading PD-L1 checkpoint inhibitor immunotherapy drugs, and with paclitaxel, a very commonly used chemotherapy agent, said Amir Jafri, Founder and CEO of Immunicom, Inc.

We have developed Immunopheresis intending that it could be used with many different oncology regimens and the growing array of promising immunotherapy drugs, while keeping in the forefront our mission of preserving patients quality of life to ensure that they can fight cancer in a compassionate and dignified way. We are confident that our breakthrough Immunopheresis technology will provide patients the benefits associated with upregulation of their immune system to attack resistant cancers. Immunicoms motto of Healing Reimagined, reflects our mission to improve quality-of-life for all patients in a meaningful way and expedite their path to a healthy recovery, continued Mr. Jafri.

For an overview of how this breakthrough technology works, visit https://www.immunicom.com/how-it-works. Immunopheresis is an investigational therapy that has not yet been approved for use by the FDA.

About Acibadem University

Acibadem University was founded in 2007 dedicated to the field of health sciences.By using dynamic and contemporary educational programs, a strong academic teaching team trains healthcare students to be future healthcare professionals who continually research innovations in all fields of medical science. With the mission of being a strongly research oriented university, the research laboratories are fitted out with the latest state of the art equipment, designed to complement the life sciences and biotechnology fields.The Clinical Simulation and Advanced Endoscopic - Robotic Surgery Training Center - CASE is one of the most comprehensive medical training centers in the world with its accommodation of multiple departments and advanced technological infrastructure. CASE received the Center of Excellence certificate awarded by the CAE Academy to only two medical training centers worldwide. The Center is accredited by the Network of Accredited Clinical Skills Centers of Europe (NASCE) and the Society for Simulation in Healthcare (SSH), providing pre- and post-graduate training.Acibadem University offers its students the opportunity to study abroad at esteemed partner universities under the Erasmus Programme having bilateral agreements with Europes most notable universities. With 100,000 square meters of in-closed area centrally located on the Asian side of Istanbul, the Kerem Aydnlar Campus is replete with high-technology equipment and offers students a privileged university life.

About Acibadem Healthcare Group

Acibadem Healthcare Group, a world brand in health sector, offers services in 21 hospitals and 13 medical centers in 4 countries, namely, Macedonia, Bulgaria and The Netherlands, besides Turkey. In addition to hospitals and medical centers, Acibadem represents Turkey as a trustworthy health brand in all over the world, with its 36 representative offices called Health Points, which are located in 22 countries and 36 cities. Acibadem brand is associated with highest standards of care and technology in the region. Today the group has reached a total capacity of 3,164 beds and 141 operating theaters with 22 thousand employees, including 4,000 physicians and 4,200 nurses working under its roof. Acibadems rapid growth led to the signing of a partnership with IHH Healthcare Berhad, Asias largest healthcare chain, in 2012 which enabled us to be a part of worlds second largest healthcare company globally by its market capitalization.

About Immunicom

Immunicom, Inc. creates novel immunotherapies designed to treat a variety of diseases using its breakthrough Immunopheresis technology platform. The privately held medical technology company develops innovative, non-pharmaceutical approaches for treating cancer, autoimmune disease, and inflammatory and renal diseases. Immunicoms revolutionary blood-filtering Immunopheresis technology has the potential to effectively treat a wide variety of cancer types, including those that have not responded to other treatment strategies, with possibly fewer side effects. Immunicoms lead product, the LW-02 column, has received U.S. FDA Breakthrough Device designation for stage IV metastatic cancer and European regulatory clearance (CE Mark Certification) for use in adults with advanced, refractory, triple negative breast cancer (TNBC). Immunopheresis is currently being evaluated in several global oncology trials for multiple cancers. Immunicom is headquartered in San Diego, California with operations in Houston, Texas, Philadelphia, Pennsylvania and Krakow, Poland.

Here is the original post:
Immunicom Continues Successful Immunopheresis Clinical Trial in Advanced, Non-Small Cell Lung Cancer Treatment with Acibadem University - Business...

Posted in Cell Medicine | Comments Off on Immunicom Continues Successful Immunopheresis Clinical Trial in Advanced, Non-Small Cell Lung Cancer Treatment with Acibadem University – Business…